News | June 22, 2009

Biosense Webster Showcases New Navigational EP Mapping System at EUROPACE

June 22, 2009 – Biosense Webster Inc. is showcasing the CARTO 3 System, an advanced three-dimensional imaging technology for use by electrophysiologists in treating cardiac arrhythmias this week at EUROPACE, the official Congress of the European Heart Rhythm Association.

The CARTO 3 System offers three unique features: Advanced Catheter Location (ACL) Technology, Fast Anatomical Mapping (FAM), and a streamlined workflow feature set referred to as Connection of Choice. The company said these three features work in tandem to enhance a physician’s ability to treat an array of simple and complex cardiac arrhythmias.

ACL allows for accurate visualization so physicians can clearly pinpoint all catheters in the anatomy with precision and clarity. It can visualize up to five catheters simultaneously with clear distinction of all electrodes. FAM quickly and accurately creates an anatomical map as a catheter is moved throughout the cardiac chamber similar to the way that a global positioning system can immediately track where a car may be. Images are high-resolution and similar to the clarity seen in CT-like maps, the company said.

Connection of Choice is enabled by a brand new CARTO hardware configuration featuring a central connection point for all catheters and equipment while preserving the signal quality of intracardiac electrograms. Catheter connections have been re-designed for “plug-and-play” functionality and automatic catheter recognition. All of these enhancements have been developed to streamline and simplify workflow in the EP lab.

“The CARTO 3 System is an exciting technology that represents a major step forward for electrophysiologists,” said professor Gerhard Hindricks, M.D., University Leipzig - Heart Center, department of cardiology, in Leipzig, Germany. “I was especially impressed with the Fast Anatomical Mapping feature. I was able to create a map quickly and the accuracy was excellent. In addition, I was pleased with how the system merged with our CT scan. Overall, the evaluation was a great experience for the whole lab team who enjoyed the new quick system set up.”

“After performing 10 procedures using the CARTO 3 technology, I believe this system will increase the use of ablation to treat Afib,” said Dr. Carlo Pappone, director of the department of arrhythmology at San Raffaele University Hospital in Milan, Italy, another of the EPs participating in the external evaluation for CARTO 3.

The CARTO 3 System will be released throughout the European Union, Australia and Canada in the third quarter of 2009. The CARTO 3 System is currently pending U.S. FDA 510(k) review and clearance.

Drs. Hindricks and Pappone are compensated for their time as consultants to Biosense Webster.

For more information: www.biosensewebster.com

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init